Fabian Hoti

2.7k total citations · 1 hit paper
61 papers, 1.8k citations indexed

About

Fabian Hoti is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Psychiatry and Mental health. According to data from OpenAlex, Fabian Hoti has authored 61 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Genetics and 13 papers in Psychiatry and Mental health. Recurrent topics in Fabian Hoti's work include Menopause: Health Impacts and Treatments (13 papers), Schizophrenia research and treatment (11 papers) and Estrogen and related hormone effects (9 papers). Fabian Hoti is often cited by papers focused on Menopause: Health Impacts and Treatments (13 papers), Schizophrenia research and treatment (11 papers) and Estrogen and related hormone effects (9 papers). Fabian Hoti collaborates with scholars based in Finland, Sweden and United States. Fabian Hoti's co-authors include Antti Tanskanen, Jari Tiihonen, Heidi Taipale, Juha Mehtälä, Pia Vattulainen, Maila Majak, Ellenor Mittendorfer‐Rutz, Erik Jedenius, Jan Sermon and Dana Enkusson and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Fabian Hoti

59 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia

2017 438 citations Jari Tiihonen, Fabian Hoti et al. profile →

Peers

Countries citing papers authored by Fabian Hoti

Since Specialization

Citations

This map shows the geographic impact of Fabian Hoti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabian Hoti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabian Hoti more than expected).

Fields of papers citing papers by Fabian Hoti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabian Hoti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabian Hoti. The network helps show where Fabian Hoti may publish in the future.

Co-authorship network of co-authors of Fabian Hoti

This figure shows the co-authorship network connecting the top 25 collaborators of Fabian Hoti. A scholar is included among the top collaborators of Fabian Hoti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabian Hoti. Fabian Hoti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Persistence of advanced systemic pharmacological treatment of moderate‐to‐severe psoriasis among bio‐naïve patients—A retrospective register‐based cohort study in Finland and Sweden 2024 ·Journal of the European Academy of Dermatology and Venereology ·(unknown), (unknown), (unknown), (unknown), Anna Westerlund, Fabian Hoti, (unknown), (unknown), Jin‐Young Lee, (unknown), I. D. Johnsson, (unknown), R Nissinen, Sam Polesie, Tarja Mälkönen, (unknown)	2
2	The sustained increase of cardiovascular risk following COPD exacerbations: meta-analyses of the EXACOS-CV studies 2024 ·ERJ Open Research ·Clémentine Nordon, Sami O. Simons, Jonathan Marshall, Hana Müllerová, Michael Pollack, Camilla Bengtsson, Fabian Hoti, Muriel Lobier, Aaro Salosensaari, Ana C. Santos, Claus Vogelmeier, Kirsty Rhodes	4
3	Prenatal exposure to pregabalin, birth outcomes and neurodevelopment – a population-based cohort study in four Nordic countries 2023 ·Drug Safety ·(unknown), Szimonetta Komjáthiné Szépligeti, Pär Karlsson, Kofi Asomaning, Anne Kjersti Daltveit, Katja M. Hakkarainen, Fabian Hoti, Helle Kieler, Astrid Lunde, Ingvild Odsbu, Matti Rantanen, Johan Reutfors, (unknown), Véra Ehrenstein, Gunnar Toft	15
4	Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands 2023 ·Respiratory Research ·Karin M. A. Swart, (unknown), (unknown), Fernie J. A. Penning‐van Beest, Camilla Bengtsson, Muriel Lobier, Fabian Hoti, Dina Vojinović, (unknown), Kirsty Rhodes, Edeltraut Garbe, Ron M. C. Herings, Clémentine Nordon, Sami O. Simons	24
5	Validation of safety outcomes in routinely collected data: Lessons learned from a multinational postapproval safety study 2022 ·Pharmacoepidemiology and Drug Safety ·(unknown), Kui Huang, (unknown), Shahram Bahmanyar, Jingping Mo, Stephen E. Schachterle, Anthony P. Nunes, (unknown), (unknown), Fabian Hoti, Pasi Korhonen, Kasper Adelborg, Jens Sundbøll, Torben Riis Rasmussen, Anders Løkke, Véra Ehrenstein	1
6	Increased risk for stress urinary incontinence in women with postmenopausal hormone therapy 2019 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Päivi Rahkola‐Soisalo, Hanna Savolainen‐Peltonen, Mika Gissler, Fabian Hoti, Pia Vattulainen, Olavi Ylikorkala, Tomi S. Mikkola	1
7	Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study 2019 ·BMJ ·Hanna Savolainen‐Peltonen, Päivi Rahkola‐Soisalo, Fabian Hoti, Pia Vattulainen, Mika Gissler, Olavi Ylikorkala, Tomi S. Mikkola	92
8	Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control study 2019 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Hanna Savolainen‐Peltonen, Päivi Rahkola‐Soisalo, Fabian Hoti, Pia Vattulainen, Mika Gissler, Olavi Ylikorkala, Tomi S. Mikkola	1
9	Postmenopausal hormone therapy is accompanied by elevated risk for uterine prolapse 2018 ·Menopause The Journal of The North American Menopause Society ·Päivi Rahkola‐Soisalo, Hanna Savolainen‐Peltonen, Mika Gissler, Fabian Hoti, Pia Vattulainen, Olavi Ylikorkala, Tomi S. Mikkola	9
10	Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder 2018 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Markku Lähteenvuo, Antti Tanskanen, Heidi Taipale, Fabian Hoti, Pia Vattulainen, Eduard Vieta, Jari Tiihonen	4
11	Increased risk for stress urinary incontinence in women with postmenopausal hormone therapy 2018 ·International Urogynecology Journal ·Päivi Rahkola‐Soisalo, Hanna Savolainen‐Peltonen, Mika Gissler, Fabian Hoti, Pia Vattulainen, Olavi Ylikorkala, Tomi S. Mikkola	13
12	Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study 2018 ·BMC Pulmonary Medicine ·Gunnar Johansson, (unknown), Tobias Bäckström, (unknown), Mona Aeysha Khalid, (unknown), Fabian Hoti	22
13	Increased cardiac and stroke death risk in the first year after discontinuation of postmenopausal hormone therapy 2017 ·Menopause The Journal of The North American Menopause Society ·(unknown), Hanna Savolainen‐Peltonen, Päivi Rahkola‐Soisalo, Fabian Hoti, Pia Vattulainen, Mika Gissler, Olavi Ylikorkala, Tomi S. Mikkola	13
14	Lower Death Risk for Vascular Dementia Than for Alzheimer's Disease With Postmenopausal Hormone Therapy Users 2017 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Tomi S. Mikkola, Hanna Savolainen‐Peltonen, Pauliina Tuomikoski, Fabian Hoti, Pia Vattulainen, Mika Gissler, Olavi Ylikorkala	2
15	Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study 2016 ·Menopause The Journal of The North American Menopause Society ·Tomi S. Mikkola, Hanna Savolainen‐Peltonen, Pauliina Tuomikoski, Fabian Hoti, Pia Vattulainen, Mika Gissler, Olavi Ylikorkala	25
16	Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality 2015 ·Menopause The Journal of The North American Menopause Society ·Tomi S. Mikkola, Pauliina Tuomikoski, Heli Lyytinen, Pasi Korhonen, Fabian Hoti, Pia Vattulainen, Mika Gissler, Olavi Ylikorkala	77
17	Advanced backcross-QTL analysis in spring barley (H. vulgare ssp. spontaneum) comparing a REML versus a Bayesian model in multi-environmental field trials 2009 ·Theoretical and Applied Genetics ·(unknown), Fabian Hoti, Maria von Korff, Klaus Pillen, Jens Léon, Mikko J. Sillanpää	22
18	Clustering of serotypes in a longitudinal study of Streptococcus pneumoniae carriage in three day care centres 2008 ·BMC Infectious Diseases ·Tuija Leino, Fabian Hoti, Ritva Syrjänen, Antti Tanskanen, Kari Auranen	19
19	Bayesian mapping of genotype × expression interactions in quantitative and qualitative traits 2006 ·Heredity ·Fabian Hoti, Mikko J. Sillanpää	63
20	Family-based clusters of cognitive test performance in familial schizophrenia 2004 ·BMC Psychiatry ·Fabian Hoti, Annamari Tuulio‐Henriksson, Jari Haukka, Timo Partonen, Lasse Holmström, Jouko Lönnqvist	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact